Monoclonal Antibody Study Drives Seven Fold Increase In Covid Treatment
A study from the University of Pittsburgh Medical Center (UPMC) has shown that monoclonal antibodies—when used to treat COVID-19 patients soon after their diagnosis—significantly decrease hospitalization and death from the disease. Before the study, which was completed in partnership with the White House COVID-19 Response Team, a small percentage of eligible patients in the U.S. were able to receive the potentially lifesaving treatment. “Now, we’re able to offer monoclonal antibodies in the context of a clinical trial at every single one of our available treatment sites—resulting in a 7....